Crossmark

[18F]MFBG PET/CT imaging of myocardial sympathetic innervation in healthy controls and patients with parkinson’s disease: dosimetry and pharmacokinetics

Crossref DOI link: https://doi.org/10.1007/s00259-025-07517-3

Published Online: 2025-09-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Versweyveld, Louis https://orcid.org/0009-0008-3475-1079
Delva, Aline

Cohilis, Marie

Deroose, Christophe M.

Van Weehaeghe, Donatienne

Koole, Michel

Vandenberghe, Wim

Van Laere, Koen
Funding

Funding for this research was provided by:

Fonds Wetenschappelijk Onderzoek (T001223N)
License Information

Text and Data Mining valid from 2025-09-09

Version of Record valid from 2025-09-09
More Information

Article History

Received: 5 May 2025

Accepted: 4 August 2025

First Online: 9 September 2025

Declarations

:

: This study received ethical approval via the Clinical Trials Information System (CTIS) platform in compliance with the EU Clinical Trials Regulation (EU CTR 536/2014) under trial reference number EU CT 2023-506508-18-00.

: All participants provided written informed consent prior to participation.

: The authors have no relevant financial or non-financial interests to disclose.

Document is current

Any future updates will be listed below